A clinical overview links scalp inflammation with shedding and scratching with breakage. AAD guidance explains why treatment depends on the condition.
On October 31, 2026, Acibadem International published a clinical overview of scalp buildup and dryness alongside itching and hair quality. Its central message is practical: persistent itch and scale may reflect an inflammatory scalp condition rather than a purely cosmetic concern.
The overview links inflammation with possible shedding and describes how scratching or picking at scale can break hairs. Read alongside guidance from the American Academy of Dermatology (AAD), it offers a useful way to think about scalp discomfort: identify the condition before judging the treatment claim.
Acibadem International names seborrheic dermatitis and scalp psoriasis among conditions associated with scalp inflammation and increased shedding. It also describes a separate mechanical issue: scratching and picking can break the hair shaft.
Breakage and shedding should therefore stay distinct in a discussion about hair changes. In the overview, breaking a hair through scratching is a mechanical problem. Increased shedding is discussed in connection with inflammation. Grouping both under the broad label of hair loss can hide the distinction the source is making.
The overview also describes different appearances of scale:
These descriptions bring the scalp itself into the conversation about changing hair quality. Persistent symptoms deserve attention alongside concerns about the hair's appearance.
For related background, Younell's guide to scalp symptoms and their possible explanations provides a broader reading path.
The AAD's guidance gives the overview a more specific treatment context. For mild-to-moderate scalp seborrheic dermatitis, it says dandruff shampoo can be a treatment. It also identifies ketoconazole among the medications dermatologists may prescribe to reduce rash and itching as well as scale.
That is a recommendation tied to a particular condition and level of severity. It is more specific than a general promise about scalp health.
For scalp psoriasis, the AAD describes several treatment categories:
The appropriate choice depends on the condition and its severity. A shampoo is therefore one possible part of psoriasis care rather than a complete answer for every case.
The practical distinction is between a broad cosmetic goal and treatment directed at an identified inflammatory condition. A claim about scalp cleanliness is not equivalent to a treatment recommendation for seborrheic dermatitis or psoriasis. The useful question is which approach addresses the condition being assessed.
Acibadem International's article is health information, not a report of a new clinical trial or a newly announced treatment. It provides no participant sample or measured effect size for the inflammation and shedding association. There is no quantified risk or incidence rate to apply to an individual reader.
The association also does not establish that scalp inflammation explains a particular person's hair loss. Likewise, the visual descriptions of scale are reasons to seek assessment rather than substitutes for diagnosis. The sources do not establish that treating a scalp condition will reverse every form of hair loss.
The AAD guidance supports condition-specific treatment options. It does not report a clinical trial comparing those options with cosmetic scalp products. The evidence supports a medical distinction between conditions and their treatments, not a blanket claim that every medicated product outperforms every cosmetic one.
For someone with persistent itching or scale alongside hair concerns, the practical step supported by the guidance is evaluation by a qualified clinician. The goal is to connect the symptoms with a condition-specific approach rather than choose a product from a broad scalp-care claim.
Useful questions for that discussion include:
These questions keep the appointment focused on the concern being treated. They also separate two issues that can become blurred: what is happening on the scalp and what is happening to the hair.
Application details belong in that discussion too. The AAD advises using dandruff shampoo as directed and leaving it on the scalp for the time recommended by a dermatologist. Its guidance notes that frequency can vary with hair type and texture. Those details support an individualized conversation rather than a universal shampoo schedule.
Acibadem International's description of mechanical breakage also gives a reason not to respond to persistent scale with aggressive scratching or picking. Removing visible scale by force is a different action from treating the condition associated with it.
For a broader view of the assessment conversation, Younell's article on bringing shedding concerns into a dermatology discussion offers related reading. Personal treatment decisions belong with a qualified professional who can assess the scalp and the hair concerns together.
A useful next research question is how treatment of a defined inflammatory scalp condition affects itch and scale alongside separately measured shedding and breakage. Keeping those outcomes distinct would make future claims easier to judge. Symptom relief and changes in hair are different outcomes worth assessing on their own terms.
For now, the grounded takeaway is that persistent scalp symptoms deserve more than a cosmetic explanation by default. The AAD describes condition-specific treatment pathways for seborrheic dermatitis and scalp psoriasis. Understanding which condition is present is the starting point for a more meaningful care discussion.
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
